| abstract |
The present invention describes new virus-like particles for use as vaccines, diagnostic tools and R & D tools based on recombinant DNA technology and cell culture technology for production. The recombinant virus-like particles of the present invention can be from either (a) different virus strains of the same virus and / or (b) different serotypes of the same virus and / or (c) different virus strains specific for different hosts. It is associated by a selected polypeptide chain incorporating several, particularly two or more different epitopes. These epitopes are then displayed on the particle surface. |